Drug Development 2023 Events

Call for Abstract

Scientific Program

2^nd Annual Meeting on Pharmaceutical Science and Drug Manufacturing and Development, will be organized around the theme “â€œExploring the Recent Advancements in Drug Development and Pharmaceutical science â€ ”

Drugdevelopment-2023 is comprised of 10 tracks and 0 sessions designed to offer comprehensive sessions that address current issues in Drugdevelopment-2023.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Track 1:Research and development in the pharmaceutical industry

Medicinal analysis is a type of analysis used to determine the standard and amount of pharmaceutical items. It also provides information on the products' purity and safety. It is frequently defined in terms of identifying, determining, quantifying, purifying, and isolating the active ingredient from the mixture.

Track 2:Drug discovery and Development

Drug discovery and Development is a discipline of pharmacy in which the creation of powerful drug entities plays a key role. The identification of diagnostic biomarkers, such as a protein responsible for the disease or disorder, and the development of a pharmacological molecule with therapeutic potency that targets it, is a major element of drug design. Various fields of pharmacology come together with biotechnology, bioinformatics, molecular biology, nanotechnology, and biochemistry in this process, which leads to the synthesis of medicinal compounds. Despite advances in modern technology and a better knowledge of biological systems, the drug discovery process remains a time-consuming and costly endeavor.

• Diagnostic indicators as therapeutic targets

• Methodologies for identifying and validating targets

• In silicon pharmacology

• Drug design and molecular modeling

• Molecular docking studies

Track 3:Drug Delivery Technologies Pharmaceutical Delivery

Technology is primarily focused on increasing medicine retention, tolerant experience, and drug adequacy. Expanding the disintegration rate with specific medicine conveyance upgrade items is frequently used to increase the bioavailability of prescriptions within the system. It is possible to increase its company success by increasing the most recent technologies for drug delivery. Oral, infusion/mixture, and transdermal are the three most common routes for pharmaceutical delivery. Pharmaceutical eluting stents and other implantable medication conveyance devices, as well as remotely applied devices, are discussed. Drug-coated nanoparticles, drug-epitomizing liposomes and nanotubes, and tree-like dendrites, when combined with appropriate targeting moieties, enable organ and tissue targeting.

We may witness the rapid spread of nanotechnology in the field of medication and visible in various parts of medication conveyance in this year. In the current circumstances, several chemicals are being investigated for the treatment of pharmaceutical conveyance, with a particular focus on cancer treatment. Furthermore, drug sciences are now using nanoparticles to reduce the symptoms of drugs, even if they don't grasp the transporter structure, which puts the patient at risk.

The dangers posed by using nanoparticles for drug delivery go beyond those posed by classic perils posed by synthetics in old-style drug delivery networks.

Track 4:Drug Delivery and Design Development

In this session, we'll focus on Medical Devices that deliver drugs via the pulmonary and nasal routes. These courses are useful for local delivery, such as in asthma, as well as for fast delivery of drugs to the framework flow and direct delivery to the focus sensory system. Intranasal and pneumonic courses that are anatomically and mentally accounted for may be included. Medicine conveyance devices are specific devices that are used to deliver a medication via a predetermined route of administration. At least one clinical drug contains such devices. Because many industries believe it is needless to see health care as a posh issue, they are delaying the implementation of improved health-care standards.

But, in order to change that attitude, the FDA said last year that it will invest roughly $40 million in a new Medical Device Innovation Consortium (MDIC) tasked with making the process of inventing and testing new technology easier. MDIC will priorities the regulatory science needs of the community and support rising projects to streamline the process with participation from industry, government, and some non-profit organizations, as well as some public-private partnerships.

Current research on femtosecond laser micro manufacturing of fluidic devices is presented in order to elaborate on their findings. Microfluidics research areas offer a wide range of sensitive microfluidic sensors for practical applications, with the added benefits of cheap cost, portability, sensitivity, and versatility.

Track 5:Drug Discovery and Nanotechnology

As we have seen in recent days, nanotechnology has become the most significant subject of interest to a wide range of areas in the pharmaceutical sector. In vivo preclinical and clinical experiments, nanomaterial’s are used. The delivery routes, dose, drug target, drug physicochemical qualities, and target cells or tissues all influence which techniques or methodologies are used. Medication delivery and drug compositions have been studied using a variety of Nano scale architectures. Drug carriers including nanomaterial include Nano-sized crystalline drugs, drug-polymer and drug-antibody conjugates, dendrites, liposomes, lipid emulsions, and solid drug-polymer nanoparticle dispersions.

Therapeutic properties of nanomaterial’s
Nanoparticles as drug vehicles
Role of nanotechnology in drug design and manufacture
Biocompatibility of nanoparticles
Regenerative Therapeutics

Track 6:Pharmaceutical Drug Discovery and Nanotechnology

Nanotechnology is now being used in the development of medicine. Nanotechnology entails the use of materials with critical length scales inside the nanometer measurement that exhibit considerably different properties than micron-structured materials. Particles, fibers, grain sizes, and other materials are examples of such materials. This session focused on the advancements made by nanotechnology in medicine in areas such as disease prevention, diagnosis, and treatment, including (but not limited to) drug delivery, tissue engineering, implants, sensors, cancer treatment, and toxicology, including (but not limited to) drug delivery, transplants, tissue engineering, and toxicology.

Track 7:The Role of Medicinal Chemistry in Drug Development

The most recent drug discovery system has resulted in numerous improvements and developments in the field of new medications. New organic targets, procedures, and advanced calculating have improved current drug discovery and offered therapeutic research a more insightful variety of skills and toolset to hold the subtleties of infection pathophysiology. Drug distribution is more efficient and attrition is reduced when medicinal chemistry and technique are used in drug discovery. Structure-based medication plans, piece-based medication plans, regular item-based medication plans, variety-based medication plans, and chemo genomics are all used in medication planning.

Protein Kinases in Immunology and Oncology
Medicinal Chemistry Inhibitors
Medicinal Chemistry for Autoimmune Diseases
Neuroscience Drug Discovery
CNS – Interfacing Chemistry and Biology to Advance

Track 8:Pharmacy Computer Applications

Computers are increasingly widely used in pharmaceutical industries, hospitals, and other industries for drug knowledge, education, evaluation, analysis, prescription history, and financial record keeping. In the fields of clinical pharmacy, hospital pharmacy, and pharmaceutical research, they have become indispensable. Patients' profiles, medicine, monitoring, management, and material management can all be done with computers. It comes in handy when it comes to drug information, drug interactions, and patient counseling.

Track 9:Drug Design with the Help of Computers (CADD)

The method of developing a replacement drug using bioinformatics has paved the way for a new area of medication research and development. Drug-Formulation planning and going through different medicine objectives are made easier with computational methodologies.

Within the following drug design path, drug formulation and new drug design are affected by Drug Discovery 2023 and bioinformatics.

We can now investigate the precise underlying molecular and atomic interactions involved in ligand: protein interactions using computational methods and the 3D structural information of the protein target, and so interpret experimental results in depth. The use of computers in medication formulation and discovery has the added benefit of delivering new therapeutic candidates more quickly and at a lower cost. New ligands are predicted with their receptor-bound structures, and in certain cases, the achieved hit rates (ligands discovered per molecules screened) are much higher than through experimental high-throughput screening.

Track 10:Science of Pharmaceuticals

Pharmaceutical sciences encompass a wide range of scientific disciplines that are vital to the research and invention of new medications and cures. Pharmaceutical sciences are frequently divided into the following primary divisions, each of which has numerous sub-categories.

Pharmaceutical experts have contributed to the discovery and development of new pharmaceuticals that have saved thousands of lives and improved the quality of life for many others over the years. Pharmaceutical scientists have a wide range of career options. They work for pharmaceutical businesses, as pharmacists, doctors, and university academics and professors, as regulatory scientists for government organizations such as the Food and Drug Administration (FDA), and as researchers at national laboratories such as the National Institutes of Health (NIH).

2^nd Annual Meeting on Pharmaceutical Science and Drug Manufacturing and Development October 24-25, 2023 Paris, France

Recommended Global Medical Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Call for Abstract

Scientific Program

Track 1:Research and development in the pharmaceutical industry

Track 2:Drug discovery and Development

Track 3:Drug Delivery Technologies Pharmaceutical Delivery

Track 4:Drug Delivery and Design Development

Track 5:Drug Discovery and Nanotechnology

Track 6:Pharmaceutical Drug Discovery and Nanotechnology

Track 7:The Role of Medicinal Chemistry in Drug Development

Track 8:Pharmacy Computer Applications

Track 9:Drug Design with the Help of Computers (CADD)

Track 10:Science of Pharmaceuticals

Conference Series Destinations

Webinars & Conferences By Continents

Americas

Asia-Pacific

Europe

Medical & Clinical Webinars & Conferences

Webinars & Conferences By Subject